Endocrine–exocrine signals in obesity-associated pancreatic cancer
Author:
- 1 June 2020
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 17 (8) , 455-456
Abstract
Obesity is a known risk factor for pancreatic cancer. Now, a new study reports that obesity accelerates early pancreatic cancer development and growth in mice through local perturbations in the pancreatic microenvironment and implicates pancreatic islet-derived cholecystokinin as a driving factor.Keywords
This publication has 10 references indexed in Scilit:
- Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaCell, 2020
- Cancer statistics, 2020CA: A Cancer Journal for Clinicians, 2020
- Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptorAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2018
- Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directionsNature Reviews Gastroenterology & Hepatology, 2018
- Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse ModelScientific Reports, 2018
- Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United StatesCA: A Cancer Journal for Clinicians, 2017
- Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D micePLOS ONE, 2017
- Acinar cell plasticity and development of pancreatic ductal adenocarcinomaNature Reviews Gastroenterology & Hepatology, 2017
- Body Fatness and Cancer — Viewpoint of the IARC Working GroupNew England Journal of Medicine, 2016
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014